Detection of CDR3s diversity and its prediction of persistent high-risk HPV infection and cervical intraepithelial neoplasia risk: a prospective study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000038164

Enrollment

Unknown

Registered

2020-09-11

Start date

2016-10-01

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical lesions

Interventions

normal cytology group:Nil

hr-HPV group:Nil

CIN1 group:Nil

CIN2/3 group:treat

cancer group:treat

Eligibility

Sex/Gender

Female

Age

27 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 30 to 64 years; 2. Sign informed consent;

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. With history of cervical surgery.

Design outcomes

Primary

Measure	Time frame
complementarity-determining region 3s;HPV test;ThinPrep cytology test;cervical biopsy;	—

Countries

China

Contacts

Public ContactGuangdong Liao

West China Second University Hospital; Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education

Guangdong_Liao@163.com+86 28 85501633

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026